Study Population
Data were extracted for all eligible patients. Inclusion criteria
included patients less than 1 year of age who received sirolimus
treatment primarily for the management of chylous effusion and required
chest tube for the management of effusion due to respiratory distress.
Patients of both genders and all races/ethnicities were included.
Patients were excluded from the study if they did not have a chest tube
at the time of treatment initiation with sirolimus, or had incomplete
documentation of chest tube output after sirolimus was started.